Skip to content
★ Sign in to follow
HL

Hexima Limited. Stock: price and insider trades · Australia

ISIN AU0000111932AU·

Hexima Limited.: what insiders have been doing

Headquartered in Australia, Hexima Limited. is a listed company and traces its origins to 1998. Filings by its managers are published through ASX. From 22 October 2025 to 22 October 2026, the disclosure feed for Hexima Limited. logged 2 filings by 2 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

For context, the typical company on the same exchange (median of 1,590 companies) published 4 filings over the same period, against 2 filings here.

Insider buying of Hexima Limited. has been absent for the past year.

Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Australia · Founded: 1998

Source: Wikidata (CC0).

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2024

FY ended June 2024 · cache

A$0.01
Analyst consensus
·
Income statement
EBITDA-A$1M
Net income-A$933.9k0.0% margin
Valuation
P/Book2.2x
Beta0.87
Balance sheet & cash
Free Cash Flow-A$202k
Profitability & ownership
ROE-25.5%
ROA-18.0%
% insiders64.1%
% institutions0.0%
Last declaration on 20 October 2026
Declarations2 total
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXISIN AU0000111932ASX:2924-03150886-3A704533
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXISIN AU0000111932ASX:2924-03150883-3A704531

2 of 2 declarations

About Hexima Limited.

HEXIMA LIMITED is a company listed on the XASX, focused on developing innovative therapeutic treatments. It primarily concentrates on infectious diseases and immune disorders.